Atlas Trials

Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis

Clinical trial NCT05511766 · COMPLETED

Trial details

NCT number
NCT05511766
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
CirrhosisHepatic EncephalopathyAscitesVaricesSBP - Spontaneous Bacterial Peritonitis
Start date
2022-11-15
Primary completion
2026-01-25
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.